Vedanta Biosciences
PrivateLast Round
Grant
Apr 30, 2024
Total Funding Raised
$277.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Vedanta Biosciences is a biotechnology company that develops microbiome-based oral therapies for the treatment of immune-mediated and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vedanta Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Vedanta Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 30, 2024 | ||||
| VC Round | Apr 25, 2023 | ||||
| Series D | Jul 21, 2021 | ||||
| Grant | Sep 30, 2020 | ||||
| Grant | Dec 5, 2019 | ||||
Series C Extension | Sep 23, 2019 |
Key People
Founding team and executive leadership
Vedanta Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series C Extension, Series C |
| AMR Action Fund | VC Round |
| SymBiosis Capital Management | Series D, Series C Extension, Series C |
| Invesco Ltd. | Series C, Series B |
| Administration for Strategic Preparedness and Response | Grant |
| Salica Investments | VC Round |
| Korea Investment Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Lead asset VE303 enters Phase 3 trial for C. difficile infection.
- Aug 13, 2025
24 employees impacted due to manufacturing needs.
Vedanta Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vedanta Biosciences's valuation, stock price, and market status.